Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 93

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study

BLAIR, JENNIFER, SCAHILL, LAWRENCE, STATE, MATTHEW, MARTIN, ANDRÉS · 2005 · Journal of the American Academy of Child & Adolescent Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.chi.0000145372.61239.bb

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 38

  1. Algra, 1993, QT interval variables from 24 hour electrocardiography and the two year risk of sudden death, Br Heart J, 70, 43, 10.1136/hrt.70.1.43 · DOI · Paper page
  2. Al-Khatib, 2003, What clinicians should know about the QT interval, JAMA, 289, 2120, 10.1001/jama.289.16.2120 · DOI · Paper page
  3. Aman, 1987, The aberrant behavior checklist: factor structure and the effect of subject variables in American and New Zealand facilities, Am J Ment Defic, 91, 570
  4. Anderson, 2002, Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management, Am Heart J, 144, 769, 10.1067/mhj.2002.125804 · DOI
  5. Arato, 2002, A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study, Int Clin Psychopharmacol, 17, 207, 10.1097/00004850-200209000-00001 · DOI · Paper page
  6. Bazett, 1918, An analysis of the time-relations of electrocardiograms, Heart, 7, 353
  7. Bednar, 2001, The QT interval, Prog Cardiovasc Dis, 43, 1
  8. Blair, 2004, Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology, J Neural Transm, 111, 791, 10.1007/s00702-004-0153-8 · DOI
  9. Daniel, 1999, Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group, Neuropsychopharmacology, 20, 491, 10.1016/S0893-133X(98)00090-6 · DOI · Paper page
  10. Desta, 1999, Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6), Clin Pharmacol Ther, 65, 10, 10.1016/S0009-9236(99)70117-7 · DOI
  11. Flockhart, 2000, Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome, J Clin Psychopharmacol, 20, 317, 10.1097/00004714-200006000-00005 · DOI
  12. Fulop, 1987, ECG changes during haloperidol and pimozide treatment of Tourette's disorder, Am J Psychiatry, 144, 673, 10.1176/ajp.144.5.673 · DOI
  13. Garson, 1993, How to measure the QT interval-what is normal?, Am J Cardiol, 72, 14B, 10.1016/0002-9149(93)90034-A · DOI · Paper page
  14. Gutgesell, 1999, AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs, J Am Acad Child Adolesc Psychiatry, 38, 1047, 10.1097/00004583-199908000-00022 · DOI
  15. Honig, 1992, Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin, Clin Pharmacol Ther, 52, 231, 10.1038/clpt.1992.135 · DOI · Paper page
  16. Jurima-Romet, 1994, Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals, Drug Metab Dispos, 22, 849
  17. Kautzner, 2002, QT interval measurements, Card Electrophysiol Rev, 6, 273, 10.1023/A:1016389227576 · doi:10.1023/a:1016389227576
  18. Keck, 2001, Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies, J Clin Psychopharmacol, 21, 27, 10.1097/00004714-200102000-00007 · DOI
  19. Keck, 2003, Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial, Am J Psychiatry, 160, 741, 10.1176/appi.ajp.160.4.741 · DOI · Paper page
  20. Labellarte, 2003, The relevance of prolonged QTc measurement to pediatric psychopharmacology, J Am Acad Child Adolesc Psychiatry, 42, 642, 10.1097/01.CHI.0000046860.56865.25 · doi:10.1097/01.chi.0000046860.56865.25
  21. Leckman, 1989, The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity, J Am Acad Child Adolesc Psychiatry, 28, 566, 10.1097/00004583-198907000-00015 · DOI · Paper page
  22. Malik, 2001, Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling, Drug Saf, 24, 323, 10.2165/00002018-200124050-00001 · DOI · Paper page
  23. McDougle, 2002, Case series: use of ziprasidone for maladaptive symptoms in youths with autism, J Am Acad Child Adolesc Psychiatry, 41, 921, 10.1097/00004583-200208000-00010 · DOI · Paper page
  24. Miller, 2001, Diagnostic accuracy of screening electrocardiograms in long QT syndrome I, Pediatrics, 108, 8, 10.1542/peds.108.1.8 · DOI
  25. Morganroth, 1991, Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia, Am J Cardiol, 67, 774, 10.1016/0002-9149(91)90541-R · DOI · Paper page
  26. Moss, 1993, Measurement of the QT interval and the risk associated with QTc interval prolongation: a review, Am J Cardiol, 72, 23B, 10.1016/0002-9149(93)90036-C · DOI · Paper page
  27. Moss, 1982, Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias, Mod Concepts Cardiovasc Dis, 51, 85
  28. Patel, 2002, Experience with ziprasidone, J Am Acad Child Adolesc Psychiatry, 41, 495, 10.1097/00004583-200205000-00003 · doi:10.1097/00004583-200205000-00003
  29. Pezawas, 2000, Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance, Int Clin Psychopharmacol, 15, 207, 10.1097/00004850-200015040-00003 · DOI
  30. Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
  31. Rautaharju, 1992, Sex differences in the evolution of the electrocardiographic QT interval with age, Can J Cardiol, 8, 690
  32. Reilly, 2000, QTc-interval abnormalities and psychotropic drug therapy in patients, Lancet, 355, 1048, 10.1016/S0140-6736(00)02035-3 · DOI · Paper page
  33. Sallee, 2000, Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study, J Am Acad Child Adolesc Psychiatry, 39, 292, 10.1097/00004583-200003000-00010 · DOI · Paper page
  34. Scahill, 2001, Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism, J Child Adolesc Psychopharmacol, 11, 377, 10.1089/104454601317261555 · DOI
  35. Schmidt, 2001, Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile, Eur J Pharmacol, 425, 197, 10.1016/S0014-2999(01)01188-8 · DOI · Paper page
  36. Shapiro, 1989, Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
  37. Vervaet, 1993, Reproducibility of QTc-measurements in healthy volunteers, Acta Cardiol, 48, 555
  38. Wilens, 1996, Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents, J Am Acad Child Adolesc Psychiatry, 35, 1491, 10.1097/00004583-199611000-00018 · DOI · Paper page

Cited by

See all 93

Metadata

Authors
BLAIR, J., SCAHILL, L., STATE, M., & MARTIN, A.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2005-01
Volume
44
Issue
1
Pages
73-79
ISSN
0890-8567
Cited by
93
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study. https://app.cochat.ai/papers/10.1097/01.chi.0000145372.61239.bb
The paper
BLAIR, J., SCAHILL, L., STATE, M., & MARTIN, A. (2005). Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/01.chi.0000145372.61239.bb

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.